Analyses combining the TIDE platform and Methsurv Database demonstrated that the survival prognosis, CTL infiltration level and T cell dysfunction were affected by PODNL1 methylation in multiple cancers, among which glioma was most significantly affected by methylation (Figure 10C,D). The gene discussed is PODNL1; the disease is glioma.